217 related articles for article (PubMed ID: 9802973)
21. Distinct requirements for IFNs and STAT1 in NK cell function.
Lee CK; Rao DT; Gertner R; Gimeno R; Frey AB; Levy DE
J Immunol; 2000 Oct; 165(7):3571-7. PubMed ID: 11034357
[TBL] [Abstract][Full Text] [Related]
22. Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in vivo.
Prévost-Blondel A; Roth E; Rosenthal FM; Pircher H
J Immunol; 2000 Apr; 164(7):3645-51. PubMed ID: 10725721
[TBL] [Abstract][Full Text] [Related]
23. Interferon Gamma and Contact-dependent Cytotoxicity Are Each Rate Limiting for Natural Killer Cell-Mediated Antibody-dependent Chronic Rejection.
Lin CM; Plenter RJ; Coulombe M; Gill RG
Am J Transplant; 2016 Nov; 16(11):3121-3130. PubMed ID: 27163757
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice.
Taylor MA; Chaudhary PM; Klem J; Kumar V; Schatzle JD; Bennett M
J Immunol; 2001 Oct; 167(8):4230-7. PubMed ID: 11591744
[TBL] [Abstract][Full Text] [Related]
25. The rate of the CD8-dependent initial reduction in tumor volume is not limited by contact-dependent perforin, Fas ligand, or TNF-mediated cytolysis.
Hollenbaugh JA; Reome J; Dobrzanski M; Dutton RW
J Immunol; 2004 Aug; 173(3):1738-43. PubMed ID: 15265903
[TBL] [Abstract][Full Text] [Related]
26. Delayed kinetics of tumor necrosis factor-mediated bystander lysis by peptide-specific CD8+ cytotoxic T lymphocytes.
Smyth MJ; Sedgwick JD
Eur J Immunol; 1998 Dec; 28(12):4162-9. PubMed ID: 9862352
[TBL] [Abstract][Full Text] [Related]
27. In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.
Lee SH; Bar-Haim E; Machlenkin A; Goldberger O; Volovitz I; Vadai E; Tzehoval E; Eisenbach L
Cancer Gene Ther; 2004 Mar; 11(3):237-48. PubMed ID: 14739939
[TBL] [Abstract][Full Text] [Related]
28. Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice.
Smyth MJ; Johnstone RW; Cretney E; Haynes NM; Sedgwick JD; Korner H; Poulton LD; Baxter AG
J Immunol; 1999 Aug; 163(3):1350-3. PubMed ID: 10415034
[TBL] [Abstract][Full Text] [Related]
29. Human umbilical cord blood NK T cells kill tumors by multiple cytotoxic mechanisms.
Gansuvd B; Hagihara M; Yu Y; Inoue H; Ueda Y; Tsuchiya T; Masui A; Ando K; Nakamura Y; Munkhtuvshin N; Kato S; Thomas JM; Hotta T
Hum Immunol; 2002 Mar; 63(3):164-75. PubMed ID: 11872234
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection.
Smyth MJ; Street SE; Trapani JA
J Immunol; 2003 Jul; 171(2):515-8. PubMed ID: 12847210
[TBL] [Abstract][Full Text] [Related]
31. Genetic control of natural killing and in vivo tumor elimination by the Chok locus.
Idris AH; Iizuka K; Smith HR; Scalzo AA; Yokoyama WM
J Exp Med; 1998 Dec; 188(12):2243-56. PubMed ID: 9858511
[TBL] [Abstract][Full Text] [Related]
32. T-cell subsets mediate graft-versus-myeloid leukemia responses via different cytotoxic mechanisms.
Hsieh MH; Patterson AE; Korngold R
Biol Blood Marrow Transplant; 2000; 6(3):231-40. PubMed ID: 10871148
[TBL] [Abstract][Full Text] [Related]
33. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.
Davis JE; Smyth MJ; Trapani JA
Eur J Immunol; 2001 Jan; 31(1):39-47. PubMed ID: 11169436
[TBL] [Abstract][Full Text] [Related]
34. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
36. Adoptive transfer: the role of perforin in mouse cytotoxic T lymphocyte rejection of human tumor xenografts in vivo.
Smyth MJ; Kershaw MH; Darcy PK; Trapani JA
Xenotransplantation; 1998 May; 5(2):146-53. PubMed ID: 9584828
[TBL] [Abstract][Full Text] [Related]
37. Natural killer T cell facilitated engraftment of rat skin but not islet xenografts in mice.
Gordon EJ; Kelkar V
Xenotransplantation; 2009; 16(3):135-44. PubMed ID: 19566653
[TBL] [Abstract][Full Text] [Related]
38. Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells.
Bannai M; Oya H; Kawamura T; Naito T; Shimizu T; Kawamura H; Miyaji C; Watanabe H; Hatakeyama K; Abo T
Immunology; 2000 Jun; 100(2):165-9. PubMed ID: 10886391
[TBL] [Abstract][Full Text] [Related]
39. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells.
Lee RK; Spielman J; Zhao DY; Olsen KJ; Podack ER
J Immunol; 1996 Sep; 157(5):1919-25. PubMed ID: 8757310
[TBL] [Abstract][Full Text] [Related]
40. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection sites: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens.
Yoshida R; Matsuura A; Einaga K; Ushio Y; Yamamoto N; Yoneda Y
Microbiol Immunol; 1997; 41(2):149-59. PubMed ID: 9087957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
